HGERS
TXMD icon

Householder Group Estate & Retirement Specialist’s TherapeuticsMD TXMD Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-30
Closed – – 1318
2023
Q4 		$0 Buy
+30
New +$72 ﹤0.01% 1330

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's TXMD Position: Q1 2024 in Review

Householder Group Estate & Retirement Specialist sold out of TherapeuticsMD (TXMD) in Q1 2024, closing a stake of 30 shares.

Householder Group Estate & Retirement Specialist first reported a position in TXMD in Q4 2023 and held it in 1 quarter. The position peaked at $0 in Q4 2023. 43 funds tracked by Wall St. Rank hold TXMD as of Q1 2024.

  • Householder Group Estate & Retirement Specialist reported no remaining TherapeuticsMD position as of Q1 2024 after selling out during the quarter.
  • Householder Group Estate & Retirement Specialist sold 30 TherapeuticsMD shares in Q1 2024.
  • Householder Group Estate & Retirement Specialist first reported a position in TherapeuticsMD in Q4 2023 and held it in 1 quarter.
  • Householder Group Estate & Retirement Specialist's TherapeuticsMD position peaked at $0 in Q4 2023.
  • 43 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q1 2024, filed 3 May 2024.